Carasent AB (publ) (STO:CARA)
21.08
+0.26 (1.27%)
At close: Mar 27, 2025
Carasent AB Revenue
In the year 2024, Carasent AB had annual revenue of 275.26M NOK with 12.82% growth. Carasent AB had revenue of 78.74M in the quarter ending December 31, 2024, with 20.60% growth.
Revenue
275.26M NOK
Revenue Growth
+12.82%
P/S Ratio
5.81
Revenue / Employee
1.38M NOK
Employees
199
Market Cap
1.55B SEK
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 275.26M | 31.28M | 12.82% |
Dec 31, 2023 | 243.98M | 48.72M | 24.95% |
Dec 31, 2022 | 195.26M | 58.14M | 42.40% |
Dec 31, 2021 | 137.13M | 66.55M | 94.29% |
Dec 31, 2020 | 70.58M | 22.65M | 47.26% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.03B |
Getinge AB | 34.76B |
Sectra AB | 3.30B |
Camurus AB | 1.87B |
Medicover AB | 23.97B |
Vitrolife AB | 3.61B |
Vimian Group AB | 4.29B |
Elekta AB | 17.88B |